ENTO
Entero Therapeutics
ENTO
ENTO
6 hedge funds and large institutions have $177K invested in Entero Therapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$118K |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$48.3K |
| 3 |
3
Wells Fargo
San Francisco,
California
|
$57 |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$10.5K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $118K | 27,000 | +27,000 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $48.3K | 10,847 | +10,847 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $10.5K | 2,393 | -443 | -16% |
|
|
4
Wells Fargo
San Francisco,
California
| $57 | 13 | +7 | +117% |
|
5
US Bancorp
Minneapolis,
Minnesota
| $4 | 1 | – | – |
|
|
KSWA
6
Kathleen S. Wright Associates
Pittsburgh,
Pennsylvania
| $4 | 1 | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| – | – | -1,537 | Closed |
|
|
CFGS
8
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|